Canonical ingredient
2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-methyl-, monohydrochloride
MEPIVACAINE HYDROCHLORIDE
24 linked products
Official identifiers
Names and synonyms
- 2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-methyl-, monohydrochloride (en)
- mepivacaine hydrochloride (en)
- Chlorhydrate de mépivacaïne (fr)
- Mépivacaine, chlorhydrate (fr-CA)
Source-scoped chemical properties
Every value keeps its own authority, licence and retrieval date. Conflicting values are not silently merged.
- canada dsl listing
- listed
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl bioaccumulative
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl inherently toxic aquatic
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl meets cepa categorization
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl meets environmental
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl meets human health
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl persistent
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl substance category
- Organics
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
Safety and technical documents
General references and manufacturer-specific SDS documents are kept separate.
No verified SDS or technical sheet is linked yet. This absence is explicit and does not mean that no document exists.
End-to-end traceability
Only links supported by an identified source are published. Missing evidence remains explicitly unknown.
Evidence still missing
- Country or region of origin
- Raw-material producer
- Ingredient manufacturer
- Distributor
- Transformation steps
Documented origins
No origin has been proven yet by an explicit source.
Documented organizations
No organization has been proven yet by an explicit source.
Documented transformations
No transformation step has been proven yet by an explicit source.
Method: a company’s registration country is never used as evidence of a material’s origin.
Products containing this ingredient
2% POLOCAINE DENTAL WITH LEVONORDEFRIN 1:20,000
20 · MG · ML
3% POLOCAINE DENTAL
30 · MG · ML
CARBOCAINE LIQ 2%
20 · MG · ML
CARBOCAINE 1%
10 · MG · ML
CARBOCAINE 1%
10 · MG · ML
CARBOCAINE 2%
20 · MG · ML
CARBOCAINE 2% NEO-COBEFRIN 1:20,000 LIQ
20 · MG · ML
CARBOCAINE 2% WITH NEO-COBEFRIN
20 · MG · ML
CARBOCAINE 2% WITH NEO-COBEFRIN
20 · MG · ML
CARBOCAINE 2% WITH NEO-COBEFRIN
20 · MG · ML
CARBOCAINE 3%
30 · MG · ML
CARBOCAINE 3%
30 · MG · ML
CARBOCAINE 3%
30 · MG · ML
CARBOCAINE INJ LIQ 10MG/ML
10 · MG · ML
CARBOCAINE INJ LIQ 20MG/ML
20 · MG · ML
CARBOCAINE LIQ 1%
1 · %
CARBOCAINE LIQ 1%
1 · % · %
EQUICAINE
20 · MG · ML
ISOCAINE HCL INJ 2%
20 · MG · ML
ISOCAINE HCL INJ 3%
30 · MG · ML
MEPIVICAINE HYDROCHLORIDE INJECTION, USP 3%
30 · MG · ML
SCANDONEST 2% SPECIAL INJ
20 · MG · ML
SCANDONEST 2% WITH LEVONORDEFRIN
20 · MG · ML
SCANDONEST 3% PLAIN INJ
30 · MG · ML